Article Text

Download PDFPDF
Meropenem, rifampicin and gentamicin combination therapy in a patient with complicated urinary tract infection caused by extreme drug-resistant P. aeruginosa
  1. Aslınur Albayrak1,
  2. Dolunay Merve Fakioğlu2,
  3. Esin Şenol3
  1. 1 Department of Clinical Pharmacy, Gazi Universitesi, Ankara, Turkey
  2. 2 Department of Clinical Pharmacy, Gazi University, Faculty of Pharmacy, Ankara, Turkey
  3. 3 Department of Infectious Diseases, Gazi Universitesi Tip Fakultesi, Ankara, Turkey
  1. Correspondence to Dolunay Merve Fakioğlu, Department of Clinical Pharmacy, Gazi University, Faculty of Pharmacy, Ankara, Turkey; dolunaytopuz90{at}gmail.com

Abstract

In this article, we report a case of a 25-year-old male patient who was under follow-up for nephrolithiasis and repeated urological interventions. His last operation was carried out 9 months ago for insertion of a double-J catheter. Pseudomonas aeruginosa, which is susceptible to only colistin treatment, was detected in the urine culture. Before the removal of the double-J catheter, colistin and ceftazidime antibiotics were started to prevent the risk of bloodstream infection. However, the treatment was stopped urgently due to signs of nephrotoxicity. His treatment was restarted with colistin 300 mg once as the initial loading dose, followed by 150 mg/day. However, this time, colistin neurotoxicity has developed and the treatment was again stopped. Meropenem 6 g/day, gentamicin 2 mg/kg and rifampicin 300 mg were prescribed. Negative urine culture was achieved on the fifth day of treatment.

  • infectious diseases
  • drug administration (others)
  • infection control
  • urology
  • pharmacology
View Full Text

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.